Sotalol Hydrochloride Patent Expiration

Sotalol Hydrochloride is used for treating life-threatening ventricular arrhythmias and maintaining normal sinus rhythm in patients with symptomatic atrial fibrillation/flutter. It was first introduced by Legacy Pharma Inc in its drug Betapace on Oct 30, 1992. Other drugs containing Sotalol Hydrochloride are Sotylize, Betapace Af, Sotalol Hydrochloride. 16 different companies have introduced drugs containing Sotalol Hydrochloride.


Sotalol Hydrochloride Patents

Given below is the list of patents protecting Sotalol Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sotalol Hydrochloride US11583216 Method of administering sotalol IV/switch Aug 21, 2039 Altathera Pharms Llc
Sotalol Hydrochloride US10799138 Method of administering sotalol IV/switch Apr 05, 2039 Altathera Pharms Llc
Sotalol Hydrochloride US10512620 Method of initiating and escalating sotalol hydrochloride dosing Aug 14, 2038 Altathera Pharms Llc
Sotalol Hydrochloride US11696902 Method of initiating and escalating sotalol hydrochloride dosing Aug 14, 2038 Altathera Pharms Llc
Sotylize US9724297 Sotalol compositions and uses of the same Aug 31, 2035 Azurity
Sotylize US11850222 Sotalol compositions and uses of the same Nov 19, 2034 Azurity
Sotylize US10206895 Sotalol compositions and uses of the same Apr 01, 2034 Azurity
Sotylize US11013703 Sotalol compositions and uses of the same Apr 01, 2034 Azurity



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sotalol Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Sotalol Hydrochloride.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 15 Apr, 2024 US10799138
Patent Issue Date Used in PTA Calculation 26 Dec, 2023 US11850222
Patent eGrant Notification 26 Dec, 2023 US11850222
Recordation of Patent eGrant 26 Dec, 2023 US11850222
Recordation of Patent Grant Mailed 26 Dec, 2023 US11850222
Email Notification 26 Dec, 2023 US11850222
Mail Patent eGrant Notification 26 Dec, 2023 US11850222
Email Notification 07 Dec, 2023 US11850222
Issue Notification Mailed 06 Dec, 2023 US11850222
Dispatch to FDC 13 Nov, 2023 US11850222


Sotalol Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sotalol Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Sotalol Hydrochloride. The first generic version for Sotalol Hydrochloride was by Natco Pharma Usa Llc and was approved on May 1, 2000. And the latest generic version is by Beximco Pharmaceuticals Usa Inc and was approved on Nov 2, 2018.

Given below is the list of companies who have filed for Sotalol Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. All of these versions come by the name SORINE. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Prescription ORAL AB Apr 27, 2001
160MG

tablet Prescription ORAL AB Apr 27, 2001
240MG

tablet Prescription ORAL AB Apr 27, 2001
120MG

tablet Prescription ORAL AB Apr 27, 2001





2. APOTEX

Apotex Inc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Prescription ORAL AB Aug 27, 2003
240MG

tablet Prescription ORAL AB Sep 26, 2002
160MG

tablet Prescription ORAL AB Aug 27, 2003
120MG

tablet Prescription ORAL AB Aug 27, 2003


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
Etobicoke Apotex, Inc.
Brantford Apotex Pharmachem Inc.
Winnipeg Apotex Fermentation Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.





3. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 3 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Prescription ORAL AB Feb 7, 2007
120MG

tablet Prescription ORAL AB Feb 7, 2007
160MG

tablet Prescription ORAL AB Feb 7, 2007


Manufacturing Plant Locations
New

Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.

Country City Firm Name
United States
East Windsor Aurobindo Pharma USA Inc





4. BEXIMCO PHARMS USA

Beximco Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
160MG

tablet Prescription ORAL AB Nov 2, 2018
80MG

tablet Prescription ORAL AB Nov 2, 2018
120MG

tablet Prescription ORAL AB Nov 2, 2018





5. EPIC PHARMA LLC

Epic Pharma Llc has filed for 3 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
160MG

tablet Prescription ORAL AB Nov 4, 2005
80MG

tablet Prescription ORAL AB Nov 4, 2005
120MG

tablet Prescription ORAL AB Nov 4, 2005





6. IMPAX PHARMS

Impax Pharmaceuticals has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
240MG

tablet Discontinued ORAL N/A Nov 7, 2000
80MG

tablet Discontinued ORAL N/A Nov 7, 2000
120MG

tablet Discontinued ORAL N/A Nov 7, 2000
160MG

tablet Discontinued ORAL N/A Nov 7, 2000





7. NATCO PHARMA USA

Natco Pharma Usa Llc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Natco Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
120MG

tablet Discontinued ORAL N/A May 1, 2000
160MG

tablet Discontinued ORAL N/A May 1, 2000
240MG

tablet Discontinued ORAL N/A May 1, 2000
80MG

tablet Discontinued ORAL N/A May 1, 2000





8. OXFORD PHARMS

Oxford Pharmaceuticals Llc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Oxford Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
160MG

tablet Prescription ORAL AB Nov 7, 2003
120MG

tablet Prescription ORAL AB Nov 7, 2003
80MG

tablet Prescription ORAL AB Nov 7, 2003
240MG

tablet Prescription ORAL AB Nov 7, 2003





9. RISING

Rising Pharma Holdings Inc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
240MG

tablet Discontinued ORAL N/A Dec 19, 2000
80MG

tablet Discontinued ORAL N/A Dec 19, 2000
120MG

tablet Discontinued ORAL N/A Dec 19, 2000
160MG

tablet Discontinued ORAL N/A Dec 19, 2000


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Saddle Brook Rising Pharmaceuticals, Inc.
Mount Morris Rising Creek Bakery LLC
Livingston Risingsun Iodine Products Corp.
Decatur Rising Pharma Holdings, Inc
Fort Bragg Rising Tide Sea Vegetables
East Brunswick Rising Pharma Holding, Inc.
Rising Sun Rising Sun Veterinary Clinic
Phoenix Rising Sun Farms Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





10. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Discontinued ORAL N/A Apr 8, 2004
120MG

tablet Discontinued ORAL N/A Apr 8, 2004
240MG

tablet Discontinued ORAL N/A Oct 15, 2001
160MG

tablet Discontinued ORAL N/A Apr 8, 2004





11. TEVA

Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Discontinued ORAL N/A Jul 26, 2004
160MG

tablet Discontinued ORAL N/A Jul 26, 2004
240MG

tablet Prescription ORAL AB May 1, 2000
120MG

tablet Discontinued ORAL N/A Jul 26, 2004


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
Fort Dodge TEVA Animal Health Inc
India
Bhind Teva API India Ltd- Malanpur
Gajraula, Amroha Teva API India Private Ltd.
Canada
Scarborough Teva Canada Limited
Stouffville Teva Canada Limited
Markham Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





12. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
120MG

tablet Discontinued ORAL N/A May 1, 2000
160MG

tablet Discontinued ORAL N/A May 1, 2000
240MG

tablet Discontinued ORAL N/A May 1, 2000
80MG

tablet Discontinued ORAL N/A May 1, 2000





13. WATSON LABS

Watson Laboratories Inc has filed for 4 different strengths of generic version for Sotalol Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
80MG

tablet Discontinued ORAL N/A Jul 13, 2000
120MG

tablet Discontinued ORAL N/A Jul 13, 2000
160MG

tablet Discontinued ORAL N/A Jul 13, 2000
240MG

tablet Discontinued ORAL N/A Jul 13, 2000